Agilent Technologies Inc (0HAV.L) Q4 2024: 0hav L

Executive Summary

- Agilent delivered Q4 2024 revenue of USD 1.701 billion, up 7.8% quarter-on-quarter and marginally higher year-over-year, supported by solid demand across core life sciences instrumentation. Gross profit of USD 916 million produced a gross margin of 53.85%, reinforcing the company’s ability to sustain value even as the mix shifts.

Key Performance Indicators

Revenue

1.70B

QoQ: 7.79% | YoY:0.77%

Gross Profit

916.00M

53.85% margin

QoQ: 7.13% | YoY:0.11%

Operating Income

408.00M

QoQ: 22.52% | YoY:0.00%

Net Income

351.00M

QoQ: 24.47% | YoY:-26.11%

EPS

1.23

QoQ: 26.80% | YoY:-24.54%

Revenue Trend

Margin Analysis

Key Insights

Revenue: USD 1.701B; YoY +0.77%; QoQ +7.79%
Gross Profit: USD 916M; Gross Margin 53.85%; YoY +0.11%; QoQ +7.13%
Operating Income: USD 408M; Operating Margin 23.99%; YoY 0.00%; QoQ +22.52%
Net Income: USD 351M; Net Margin 20.63%; YoY -26.11%; QoQ +24.47%
EPS (Basic): USD 1.23; EPS (Diluted): USD 1.22; YoY -24.54%; QoQ +26.80%

Financial Highlights

- Revenue: USD 1.701B; YoY +0.77%; QoQ +7.79%
- Gross Profit: USD 916M; Gross Margin 53.85%; YoY +0.11%; QoQ +7.13%
- Operating Income: USD 408M; Operating Margin 23.99%; YoY 0.00%; QoQ +22.52%
- Net Income: USD 351M; Net Margin 20.63%; YoY -26.11%; QoQ +24.47%
- EPS (Basic): USD 1.23; EPS (Diluted): USD 1.22; YoY -24.54%; QoQ +26.80%
- Operating Cash Flow: USD 481M; Free Cash Flow: USD 388M
- Cash at End of Period: USD 1.329B; Net Debt: USD 2.061B; Total Debt: USD 3.39B
- Dividend Payout: USD 68M in dividends; Dividend Payout Ratio: 19.4%
- Key efficiency/position metrics: Current ratio 2.09, Quick ratio 1.58, Cash ratio 0.70; ROA 2.94%, ROE 5.95%, ROCE 4.26%
- Balance sheet: Total assets USD 11.846B; Total liabilities USD 5.948B; Total equity USD 5.898B

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	1.70B	0.77%	7.79%
Gross Profit	916.00M	0.11%	7.13%
Operating Income	408.00M	0.00%	22.52%
Net Income	351.00M	-26.11%	24.47%
EPS	1.23	-24.54%	26.80%

Key Financial Ratios

currentRatio

2.09

grossProfitMargin

54.4%

operatingProfitMargin

25.2%

netProfitMargin

20.6%

returnOnAssets

2.94%

returnOnEquity

5.95%

debtEquityRatio

0.61

operatingCashFlowPerShare

$1.68

freeCashFlowPerShare

$1.36

dividendPayoutRatio

19.4%

priceToBookRatio

6.35

priceEarningsRatio

26.69

Net Income vs. Revenue

Expense Breakdown

Competitive Position

Company	Gross Margin	Operating Margin	Return on Equity	P/E Ratio
0HAV.L Focus	53.85%	25.20%	5.95%	26.69%
0HBH.L	34.00%	26.20%	11.50%	8.44%
0EDE.L	53.70%	26.60%	5.39%	26.68%
0R2M.L	81.80%	27.10%	3.13%	20.69%
0HOY.L	58.60%	12.90%	2.60%	58.19%

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q3 2025	1,738.00	1.18	+10.1%	View
Q2 2025	1,668.00	0.75	+6.0%	View
Q1 2025	1,681.00	1.11	+1.4%	View
Q4 2024	1,701.00	1.22	+0.8%	View
Q3 2024	1,578.00	0.97	-5.6%	View

Agilent Technologies Inc (0HAV.L) Q4 2024 Earnings Report

Earnings Highlights

Agilent Technologies Inc (0HAV.L) QQ4 2024 Results Analysis: Robust cash generation and margin durability amid earnings mix pressures

Executive Summary

Key Performance Indicators

Revenue

Gross Profit

Operating Income

Net Income

EPS

Revenue Trend

Margin Analysis

Key Insights

Financial Highlights

Income Statement

Key Financial Ratios

Net Income vs. Revenue

Expense Breakdown

Management Commentary

Forward Guidance

Competitive Position

Gross Profit Margin

Operating Profit Margin

Return on Equity

P/E Ratio Comparison

Investment Outlook

Key Investment Factors

Growth Potential

Profitability Risk

Financial Position

SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Historical Earnings Comparison

Agilent Technologies Inc (0HAV.L) Q4 2024 Earnings Report

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue

Gross Profit

Operating Income

Net Income

EPS

Revenue Trend

Margin Analysis

Key Insights

Financial Highlights

Income Statement

Key Financial Ratios

Net Income vs. Revenue

Expense Breakdown

Management Commentary

Forward Guidance

Competitive Position

Gross Profit Margin

Operating Profit Margin

Return on Equity

P/E Ratio Comparison

Investment Outlook

Key Investment Factors

Growth Potential

Profitability Risk

Financial Position

SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Historical Earnings Comparison

More 0HAV.L Quarterly Reports

0HAV.L

0HAV.L

0HAV.L

0HAV.L

Q4 2024 Reports in Healthcare Sector

0HBH.L

0HOY.L

Related Financial Data

Sector Analysis: Healthcare

0HAV.L Full Profile

0HAV.L Financial Statements

Earnings Calendar